Ellipsys Medical, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-09-08.
Ellipsys Medical, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on September 8, 2026. The filing reports $8.57M sold. Its industry group is Other Health Care. It names FRANK HETTMANN (Executive Officer, Director), ED CHANG (Director), MARK RITCHART (Director) (SEC Form D/A, September 8, 2026).
Selling to Ellipsys Medical, Inc.? See who runs it and how to reach them, plus this week's 44 other newly funded companies.
Is this your company?
Sell to companies like Ellipsys Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-08 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Ellipsys Medical, Inc.
Free to see. No signup.
More on the people and the money behind Ellipsys Medical, Inc., from the filings we hold.
Other Health Care raises by companies based in California, filed in September 2026, largest first.
Get an email when Ellipsys Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Ellipsys Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Ellipsys Medical, Inc. →Get the full cited report on Ellipsys Medical, Inc.
What the filing shows about Ellipsys Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Ellipsys Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Ellipsys Medical, Inc.'s address as 990 Calle Negocio, San Clemente, CA 92673.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Ellipsys Medical, Inc. →
Amended on 2026-10-14: the amount sold changed from $3,771,795 to $8,572,950; the number of investors changed from 28 to 91. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Ellipsys Medical, Inc. is a registered filer with the SEC (CIK 2153524) and has filed since 2026-09-08. 1 filing is on record, the latest on 2026-09-08.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Ellipsys Medical, Inc.'s Form D of 2026-09-08 names Frank Hettmann, Ed Chang, Mark Ritchart and 3 more as its officers, directors or promoters.
Its new offerings report $3.77M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 868 filings in Other Health Care, totalled by week. The dot is this raise, $8.57M, on the same scale — one filing against the whole group's total, so it sits low by construction.
By form type: D ×1.
| Form | Filed | On EDGAR |
|---|---|---|
| D | 2026-09-08 | open |
What the filing shows about Ellipsys Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Ellipsys Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ellipsys Medical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
This is the only filing on record for this issuer, so there is no history to read yet. Incorporated in DE. Full history on sec.gov.
Frank Hettmann is named as Executive Officer and Director on the Form D that Ellipsys Medical, Inc. filed with the SEC on 8 September 2026, one of 6 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Ed Chang is named as Director on the Form D that Ellipsys Medical, Inc. filed with the SEC on 8 September 2026, one of 6 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Mark Ritchart is named as Director on the Form D that Ellipsys Medical, Inc. filed with the SEC on 8 September 2026, one of 6 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Steve Parker is named as Director on the Form D that Ellipsys Medical, Inc. filed with the SEC on 8 September 2026, one of 6 people that filing names.
Jeffrey Hull is named as Director on the Form D that Ellipsys Medical, Inc. filed with the SEC on 8 September 2026, one of 6 people that filing names.
Brian Driscoll is named as Director on the Form D that Ellipsys Medical, Inc. filed with the SEC on 8 September 2026, one of 6 people that filing names.
6 people named on the filing — 1 holding an executive role and 5 as directors only.
Named as of the 2026-09-08 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Ellipsys Medical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Ellipsys Medical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Ellipsys Medical, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-09-07 · Health care raises, week of 2026-09-07
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ellipsys-medical-inc-form-d-000001